Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07442669 · ClinicalTrials.gov registry record · NA
Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration
A NA study, sponsored by Hackensack Meridian Health.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07442669 is a NA study that has not yet begun recruiting, run by Hackensack Meridian Health. The registered enrollment target is 100 participants.
The verdict
NCT07442669, a NA study, has not yet begun recruiting, sponsored by Hackensack Meridian Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This prospective randomized controlled study aims to determine if using a lung ultrasound score can lead to a faster diagnosis of severe respiratory distress syndrome and quicker administration of surfactant in moderately and late-preterm infants. The research will involve 100 infants, with 67 in the prospective group and 33 serving as controls. The primary goal is to shorten the time to treatment for these vulnerable newborns. The study will also assess whether this ultrasound-guided approach improves short-term respiratory outcomes. These secondary objectives include measuring any decrease in the need for and duration of mechanical ventilation, the length of non-invasive respiratory support, and the overall need for oxygen. The study population includes infants born between 27 and 34 6/7 weeks of gestation who are admitted to the NICU. Each participant will be monitored from birth until they are discharged or transferred. This research aligns with a growing body of evidence suggesting that lung ultrasound can be a valuable tool in neonatal care, potentially leading to earlier and more precise treatment for respiratory distress syndrome.
Interventions
- DIAGNOSTIC_TEST Lung ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-07-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07442669
The ClinicalTrials.gov registry entry for NCT07442669 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lung ultrasound is the first listed.
NCT07442669 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07442669 about?
NCT07442669 is a clinical study titled "Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration". This prospective randomized controlled study aims to determine if using a lung ultrasound score can lead to a faster diagnosis of severe respiratory distress syndrome and quicker administration of surfactant in moderately and late-preterm infants. The research will involve 100 infants, with 67 in th...
What is the current status of trial NCT07442669?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-07-01. Estimated completion is 2028-07-05.
What interventions are being tested in trial NCT07442669?
The interventions under investigation include: Lung ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07442669?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.